This is a bit surprisng. I would have expected any significant deals to come after trial results. Hopefully this is more than just option agreement with Novartis or IP transfer with the Japanese.
With Epichem in the mix it could be anything really
This is a bit surprisng. I would have expected any significant...
Add to My Watchlist
What is My Watchlist?
